Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Human Immunodeficiency Virus (HIV) Prevention Projects for Community Based Organizations, PS 10-1003, Initial Review, 6675 [2010-2918]

Download as PDF sroberts on DSKD5P82C1PROD with NOTICES Federal Register / Vol. 75, No. 27 / Wednesday, February 10, 2010 / Notices Contact Person: Jerry L. Taylor, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5202, MSC 7846, Bethesda, MD 20892, 301–435– 1175, taylorje@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflicts: Asthma and Lung Host Defense. Date: March 16, 2010. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: Everett E. Sinnett, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2178, MSC 7818, Bethesda, MD 20892, 301–435– 1016, sinnett@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, PCMB Special Emphasis Panel. Date: March 16, 2010. Time: 12 p.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: Michael M. Sveda, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2204, MSC 7890, Bethesda, MD 20892, 301–435– 3565, svedam@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Stem Cells and Development. Date: March 16, 2010. Time: 12 p.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: James Harwood, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5168, MSC 7840, Bethesda, MD 20892, 301–435– 1256, harwoodj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, PAR 09– 129: Roadmap HTS Assay for MLPCN. Date: March 18, 2010. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Nikko, 222 Mason Street, San Francisco, CA 24102. Contact Person: James J. Li, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5148, MSC 7849, Bethesda, MD 20892, 301–806–8065, lijames@csr.nih.gov. Name of Commitee: Center for Scientific Review Special Emphasis Panel, Small Business: Digestive Sciences. Date: March 18–19, 2010. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. VerDate Nov<24>2008 16:21 Feb 09, 2010 Jkt 220001 Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting) Contact Person: Bonnie L. Burgess-Beusse, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD 20892, 301–435– 1783, beusseb@mail.nih.gov. Name of Committee: AIDS and Related Research Integrated Review Group, AIDS Discovery and Development of Therapeutics Study Section. Date: March 19, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Mandarin Oriental, 1330 Maryland Avenue, SW., Washnigton, DC 20024. Contact Person: Eduardo A. Montalvo, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5108, MSC 7852, Bethesda, MD 20892, (301) 435– 1168, montalve@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research,93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 2, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–2876 Filed 2–9–10; 8:45 am] BILLING CODE 4140–01–P 6675 Community Based Organizations, PS10– 1003.’’ This meeting will be subsequent to the February 7–13, 2010 meeting published in the Federal Register on November 19, 2010, Volume 74, Number 222, Page 59985. A second meeting is necessary due to the number of applications received and unanticipated scheduling conflicts for a significant number of the appointed reviewers. Contact Person for More Information: Barbara Stewart, Deputy Director, Extramural Programs, National Center for HIV, Hepatitis and Sexually Transmitted Diseases Prevention, 1600 Clifton Road, NE., Mail Stop E–60, Atlanta, Georgia 30333, Telephone (404)498–2273, E-mail BStewart@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 3, 2010. Elaine L. Baker, Director, Management Analysis and Services Office,Centers for Disease Control and Prevention. [FR Doc. 2010–2918 Filed 2–9–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Mental Health; Notice of Closed Meetings In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the aforementioned meetings: Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Time and Date: 8 a.m.–7 p.m., March 4, 2010 (Closed). 8 a.m.–7 p.m., March 5, 2010 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘HIV Prevention Projects for Name of Committee: National Institute of Mental Health Special Emphasis Panel, National Cooperative Drug Discovery and Development Groups (NCDDDG). Date: March 1, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Vinod Charles, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Human Immunodeficiency Virus (HIV) Prevention Projects for Community Based Organizations, PS 10–1003, Initial Review PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\10FEN1.SGM 10FEN1

Agencies

[Federal Register Volume 75, Number 27 (Wednesday, February 10, 2010)]
[Notices]
[Page 6675]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-2918]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Human Immunodeficiency Virus (HIV) Prevention 
Projects for Community Based Organizations, PS 10-1003, Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the aforementioned meetings:

    Time and Date:
    8 a.m.-7 p.m., March 4, 2010 (Closed).
    8 a.m.-7 p.m., March 5, 2010 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``HIV Prevention Projects for Community Based 
Organizations, PS10-1003.'' This meeting will be subsequent to the 
February 7-13, 2010 meeting published in the Federal Register on 
November 19, 2010, Volume 74, Number 222, Page 59985. A second 
meeting is necessary due to the number of applications received and 
unanticipated scheduling conflicts for a significant number of the 
appointed reviewers.
    Contact Person for More Information: Barbara Stewart, Deputy 
Director, Extramural Programs, National Center for HIV, Hepatitis 
and Sexually Transmitted Diseases Prevention, 1600 Clifton Road, 
NE., Mail Stop E-60, Atlanta, Georgia 30333, Telephone (404)498-
2273, E-mail BStewart@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: February 3, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office,Centers for Disease 
Control and Prevention.
[FR Doc. 2010-2918 Filed 2-9-10; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.